PD-1 and CTLA-4 are both expressed on activated T cells and act to down-regulate T cell response when in contact with their ligands (20).Cancer cells have leveraged this mechanism to evade immune surveillance by expressing PD-L1 (38). This evidence concerns the gene CTLA4 and cancer.